According to the current analysis of Reports and Data, the global fertility testing market was valued at 403.7 million in 2018 and is expected to reach USD 702.3 million by the year 2026, at a CAGR of 7.1%. Fertility testing market is rising due to delay in pregnancy, and due to the late pregnancy cases, as after crossing the age of 30, female decreases the chance of conceiving and further till the age of 35, the chance of conceiving further declines. Due to this, there is a fewer number of eggs left in the ovaries, which leads to irregular or absence of a menstrual cycle, PCOS & POI further proceeds for infertility. Damaged sperm is the most common cause of male infertility. The factors driving the industry includes the rise in PCOS disorders, increasing primary ovarian insufficiency (POI) and low sperm motility.
Fertility kits are developed to check fertility in which mostly the ovulation test kits are used, for detecting luteinizing hormone (LH) level and sometimes even estrogen levels to predict the ovulation. These kits, however, do not provide exact information about ovulation. The luteinized unruptured follicle syndrome ovulation predictor fails to give proper results. Also, LH measurement predicts ovulation and cannot determine the date of ovulation or anovulation. The leading manufacturers in the industry are Clearblue (Swiss Precision Diagnostics GmbH), First Response, and Prestige. With the rise in importance of testing and development of ovulation monitors, a decline in the fertility rate globally among females, and easily accessible ovulation monitors are few other factors contributing to the market growth. As ovulation monitors are expensive and do not precisely confirm ovulation, these factors act as a restraint to the market.
Get a sample of the report @ https://www.reportsanddata.com/sample-enquiry-form/2510
Further key findings from the report
- Fertility testing market will be expanding with the increase in the number of equipment with digitalized testing, and modern fertility testing that provides data associated to hormone levels. It tracks fertility markers over a period and, creates an individualized fertility curve that gives women more information about their ovarian eggs and details about menopause.
- Telehealth solutions are a boom to the fertility testing market, the testing is done using an ovulation kit, and further, the consulting can be done through a camera video, etc.
- In the year 2018, Predictive Technology Group, Inc. had launched endometriosis risk test ARTguide. It is a noninvasive diagnostic test and was associated with detecting various genetic and endometriosis which was further leading to infertility.
- In July 2018, Merck KGaA had launched (Fertility.com), which enabled healthcare professionals and doctors to access the latest researches and scientific information and was also a help to those who were undergoing fertility treatment, this positioned Merck to be the market leader.
- IVM (In Vitro Maturation) is a procedure where immature eggs from a woman are allowed to grow in a lab, and after the eggs are mature, they’re fertilized and implanted. This process has the potential to help women with certain gynecological disorders to have children.
- Advacare Pharma (U.S.), AVA, Babystart (UK), Fertility Focus (UK), Geratherm Medical (Germany), Hilin Life Products (U.S.), Sensiia (UK), Taidoc, Medical Uebe (Germany), Valley Electronics (Switzerland) are the key players in the market.
Buy Now: https://www.reportsanddata.com/checkout-form/2510
For the purpose of this report, Reports and Data has segmented the fertility testing market on the basis of product, mode of purchase, type, application, distribution channel, end use and region:
Product Outlook (Revenue in Million USD; 2016–2026)
- Ovulation test kits
- Saliva & Strip Based
- Monitor Touch Screen
- Fertility monitors
- Urine-Based Monitors
- Pregnancy Rapid Test
- Line Indicators
- Strip/Dip Sticks
- Mid-Stream Device
- Cassettes
- Other Fertility Monitors
- Basal Body Temperature,
- Cervical Mucus,
- Perspiration Monitoring
- Male Fertility Testing Product
Mode of Purchase Outlook (Revenue in Million USD; 2016–2026)
- OTC & Non Prescription
- Prescription based
Type Outlook (Revenue in Million USD; 2016–2026)
- HCG Blood test
- HCG Urine test
- FSH Urine test
Application Outlook (Revenue in Million USD; 2016–2026)
- Female fertility testing
- Male Fertility Testing
Distribution Channel Outlook (Revenue in Million USD; 2016–2026)
- Pharmacies
- Drugstores
- Online Sales
- Hypermarkets & Supermarkets
End Use Outlook (Revenue in Million USD; 2016–2026)
- Home care
- Hospitals, Fertility Clinics,
- Others
Regional Outlook (Revenue in Million USD; 2016–2026)
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/fertility-testing-market
Table Of Content:
Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2016 – 2026
Chapter 3. Indicative Metrics
3.1. Macro-Economic Indicators
3.1.1. Delaying of pregnancy
3.1.2. Infertility Issues
3.1.3. Increase in Healthcare Spending’s
Chapter 4. Global Fertility Testing Segmentation & Impact Analysis
4.1. Global Fertility Testing Segmentation Analysis
4.2. Industrial Outlook
4.3. Market Indicators Analysis
4.3.1. Market Drivers Analysis
4.3.1.1. Rise in PCOS disorders
….
Chapter 12. Competitive Landscape
12.1. Market Revenue Share by Manufacturers
12.2. Mergers & Acquisitions
12.3. Strategy Benchmarking
12.3.1. Partnership & Agreement
12.3.2. New Product Development
12.3.3. Mergers & Acquisitions
12.3.4. Investment & Expansion
12.4. Vendor Landscape
Chapter 13. Company Profiles
13.1. Advacare Pharma
13.1.1. Company Overview
13.1.2. Financial Insights
13.1.3. Products Offered
13.1.4. Strategic Initiatives
13.2. AVA
13.2.1. Company Overview
13.2.2. Financial Insights
13.2.3. Products Offered
13.2.4. Strategic Initiatives
13.3. Babystart
13.3.1. Company Overview
13.3.2. Financial Insights
13.3.3. Products Offered
13.3.4. Strategic Initiatives
13.4. Fertility Focus
13.4.1. Company Overview
13.4.2. Financial Insights
13.4.3. Products Offered
13.4.4. Strategic Initiatives
13.5. Geratherm Medical
13.5.1. Company Overview
13.5.2. Financial Insights
13.5.3. Products Offered
13.5.4. Strategic Initiatives
13.6. Hilin Life Products
13.6.1. Company Overview
13.6.2. Financial Insights
13.6.3. Products Offered
13.6.4. Strategic Initiatives
Continue…
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development.
Media Contact
Company Name: Reports and Data
Contact Person: John Watson
Email: Send Email
Phone: +1-212-710-1370
Address:40 Wall St. 28th floor
City: New York City
State: NY 10005
Country: United States
Website: https://www.reportsanddata.com/press-release/global-fertility-testing-market